35.45
1.78%
+0.62
After Hours:
35.45
Integra Lifesciences Holdings Corp stock is currently priced at $35.45, with a 24-hour trading volume of 823.65K.
It has seen a +1.78% increased in the last 24 hours and a -8.33% declined in the past month.
The chart indicates a potential bullish trend, as the stock is above the $34.56 pivot point. If it approaches the $35.50 resistance level, significant changes may occur.
Integra Lifesciences Holdings Corp Stock (IART) Financials Data
Integra Lifesciences Holdings Corp (IART) Revenue 2023
IART reported a revenue (TTM) of $1.54 billion for the quarter ending December 31, 2023, a -1.03% decline year-over-year.
Integra Lifesciences Holdings Corp (IART) Net Income 2023
IART net income (TTM) was $67.74 million for the quarter ending December 31, 2023, a -62.48% decrease year-over-year.
Integra Lifesciences Holdings Corp (IART) Cash Flow 2023
IART recorded a free cash flow (TTM) of $73.09 million for the quarter ending December 31, 2023, a -66.38% decrease year-over-year.
Integra Lifesciences Holdings Corp (IART) Earnings per Share 2023
IART earnings per share (TTM) was $0.83 for the quarter ending December 31, 2023, a -61.57% decline year-over-year.
Integra Lifesciences Holdings Corp Stock (IART) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
De Witte Jan | President & CEO |
Mar 11 '24 |
Option Exercise |
0.00 |
205 |
0 |
18,555 |
De Witte Jan | President & CEO |
Mar 10 '24 |
Option Exercise |
0.00 |
346 |
0 |
18,696 |
Singh Harvinder | EVP & PRESIDENT, INTERNATIONAL |
Mar 10 '24 |
Option Exercise |
0.00 |
1,179 |
0 |
1,179 |
DAVIS ROBERT T. JR. | EVP & President, TT |
Mar 06 '24 |
Option Exercise |
32.59 |
8,736 |
284,663 |
58,241 |
DAVIS ROBERT T. JR. | EVP & President, TT |
Mar 06 '24 |
Sale |
36.59 |
8,348 |
305,492 |
49,893 |
De Witte Jan | President & CEO |
Jan 18 '24 |
Option Exercise |
0.00 |
597 |
0 |
18,947 |
De Witte Jan | President & CEO |
Nov 01 '23 |
Option Exercise |
0.00 |
9,814 |
0 |
22,612 |
Mosebrook Jeffrey | SVP, Fin & PAO |
Aug 09 '23 |
Sale |
44.46 |
1,177 |
52,329 |
23,458 |
De Witte Jan | President & CEO |
Jun 01 '23 |
Buy |
38.50 |
7,792 |
299,986 |
12,798 |
Schwartz Eric | EVP, Chief Legal Officer & Sec |
Jun 01 '23 |
Buy |
37.89 |
2,640 |
100,035 |
48,597 |
Integra Lifesciences Holdings Corp Stock (IART) Latest News
Integra LifeSciences (IART) Introduces MicroMatrix Flex
Zacks Investment Research
Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases
GlobeNewswire Inc.
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March
Benzinga
Analyst Scoreboard: 5 Ratings For Integra Lifesciences
Benzinga
Integra's (IART) Q4 Earnings Miss Estimates, Margins Down
Zacks Investment Research
Compared to Estimates, Integra (IART) Q4 Earnings: A Look at Key Metrics
Zacks Investment Research
About Integra Lifesciences Holdings Corp
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, orthopedics, and general surgery. The company operates in two segments, Codman Specialty Surgical, and Orthopedics and Tissue Technologies. It offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment. The company also sells approximately 60,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, it provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, the company sells hardware products, such as bone and joint fixation, and joint replacement devices; implants; and instruments, which provide for the orthopedic reconstruction of bone in the hand, wrist, elbow, and shoulder, as well as the foot, ankle, and leg below the knee in the extremity bone and joint reconstruction procedures. Integra LifeSciences Holdings Corporation offers its products directly through various sales forces and other distribution channels in the United States, Europe, and internationally. The company was founded in 1989 and is headquartered in Plainsboro, New Jersey.
Cap:
|
Volume (24h):